SEARCH

SEARCH BY CITATION

References

  • 1
    Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol. 2005;192:185662; discussion 1862–3.
  • 2
    England LJ, Levine RJ, Qian C, Morris CD, Sibai BM, Catalano PM, et al Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2002;186:103540.
  • 3
    Zhang J, Klebanoff MA, Levine RJ, Puri M, Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Obstet Gynecol. 1999;181:140713.
  • 4
    Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642649.
  • 5
    Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:64958.
  • 6
    Fisher SJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol. 2004;2:53.
  • 7
    Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:140523.
  • 8
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Schs BP, et al Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:9921005.
  • 9
    Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:555563.
  • 10
    Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab. 2003;88:234851.
  • 11
    Schmidt-Lucke C, Belgore F, Reinhold D, Ansorge S, Klein HU, Schmidt-Lucke JA, et al Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. Int J Cardiol. 2005;100:20712.
  • 12
    Kwon JY, Kim YH, Kim SH, Kang MH, Maeng YS, Lee KY, et al Difference in the expression of alpha 7 nicotinic receptors in the placenta in normal versus severe preeclampsia pregnancies. Eur J Obstet Gynecol Reprod Biol. 2007;132:359.
  • 13
    Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest. 2002;110:52736.
  • 14
    Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:3848.
  • 15
    Tohgi H, Utsugisawa K, Nagane Y. Protective effect of nicotine through nicotinic acetylcholine receptor alpha 7 on hypoxia-induced membrane disintegration and DNA fragmentation of cultured PC12 cells. Neurosci Lett. 2000;285:914.
  • 16
    Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:274556.
  • 17
    Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181:102635.
  • 18
    Lindqvist PG, Marsal K. Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstet Gynecol Scand. 1999;78:6937.
  • 19
    North RA, Taylor R, Li Zhou R, Schellenberg JC. The relationship of smoking, preeclampsia, and secretory component. Am J Obstet Gynecol. 2000;183:1369.
  • 20
    Salafia C, Shiverick K. Cigarette smoking and pregnancy II: vascular effects. Placenta. 1999;20:2739.
  • 21
    Bainbridge SA, Sidle EH, Smith GN. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses. 2005;64:1727.
  • 22
    Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci. 2000;57:20713.
  • 23
    Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol. 2007;197:363 e1–5.
  • 24
    Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, et al Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med. 2005;201:111323.
  • 25
    Hejmadi MV, Dajas-Bailador F, Barns SM, Jones B, Wonnacott S. Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol Cell Neurosci. 2003;24:77986.
  • 26
    Utsugisawa K, Nagane Y, Obara D, Tohgi H. Over-expression of alpha7 nicotinic acetylcholine receptor induces sustained ERK phosphorylation and N-cadherin expression in PC12 cells. Brain Res Mol Brain Res. 2002;106:8893.